United States - Healthcare - Summary And Key Considerations Of Recent HHS-OIG Advisory Opinion On Pharmaceutical Patient Assistance Program For Rare Disorders
On April 8, 2024, the Department of Health and Human Services Office of Inspector General (OIG) issued a long-awaited favorable Advisory Opinion (AO 24-02) for a charitable...